Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by telmanon May 26, 2023 2:56pm
164 Views
Post# 35466247

RE:RE:RE:RE:RE:RE:RE:RE:Warrants

RE:RE:RE:RE:RE:RE:RE:RE:Warrantsexactly.

still no response to my original email about the $1M per quarter alone from CARE.

After finding Tripp's email I then sent it to him directly as well and again nothing.

I plan on asking about it again on the next conference call.  Part of me wonders if they will even take my question though knowing that.

I dont know why others dont call in with questions.  Our votes alone will do nothing when it comes to directors but if we can show people frankly the bs then maybe together our next vote will count or the next one after that.  In reality though I figure once he gets the 25% vote passed through then he can float enough shares to someone that will ensure Tripp stays right where he is for a long long time.  What it looks like is ensuring that the voting power of CARE higher ups that must be livid with the performance of this SP must be countered by Tripp so he can keep his salary and thats what he is worried about.
<< Previous
Bullboard Posts
Next >>